A Safety, Tolerability, and Efficacy Study of VC-02™ Combination Product in Subjects With Type 1 Diabetes Mellitus and Hypoglycemia Unawareness

Clinical trial NCT03163511 · COMPLETED

Trial details

NCT number: NCT03163511
Sponsor: ViaCyte
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Type 1 Diabetes Mellitus With Hypoglycemia

Start date: 2017-07-06
Primary completion: 2023-10-13
Enrollment: 49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.